Nicotinamide for the treatment of heart failure with preserved ejection fraction
- 10 February 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (580)
- https://doi.org/10.1126/scitranslmed.abd7064
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent and intractable form of cardiac decompensation commonly associated with diastolic dysfunction. Here, we show that diastolic dysfunction in patients with HFpEF is associated with a cardiac deficit in nicotinamide adenine dinucleotide (NAD+). Elevating NAD+ by oral supplementation of its precursor, nicotinamide, improved diastolic dysfunction induced by aging (in 2-year-old C57BL/6J mice), hypertension (in Dahl salt-sensitive rats), or cardiometabolic syndrome (in ZSF1 obese rats). This effect was mediated partly through alleviated systemic comorbidities and enhanced myocardial bioenergetics. Simultaneously, nicotinamide directly improved cardiomyocyte passive stiffness and calcium-dependent active relaxation through increased deacetylation of titin and the sarcoplasmic reticulum calcium adenosine triphosphatase 2a, respectively. In a long-term human cohort study, high dietary intake of naturally occurring NAD+ precursors was associated with lower blood pressure and reduced risk of cardiac mortality. Collectively, these results suggest NAD+ precursors, and especially nicotinamide, as potential therapeutic agents to treat diastolic dysfunction and HFpEF in humans.Keywords
Funding Information
- Agence Nationale de la Recherche (MINOTAUR)
- Fundação para a Ciência e a Tecnologia (MINOTAUR)
- Bundesministerium für Bildung und Forschung (MINOTAUR)
- Austrian Science Fund (MINOTAUR; I3301-B31)
- Instituto de Salud Carlos III (MINOTAUR)
This publication has 62 references indexed in Scilit:
- A Novel Paradigm for Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology, 2013
- Crucial Role for Ca 2+ /Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin PhosphorylationCirculation Research, 2013
- A guide to analysis of mouse energy metabolismNature Methods, 2011
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure: A Report From the OPTIMIZE-HF RegistryJournal of the American College of Cardiology, 2007
- Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Cardiovascular DiseaseCirculation, 2007
- Development of Heart Failure in Chronic Hypertensive Dahl RatsHypertension, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouseNeuromuscular Disorders, 2004
- Toll-like Receptor 4 Polymorphisms and AtherogenesisThe New England Journal of Medicine, 2002